In an article, Stergios A. Polyzos et al. concluded that the association between Se or SELENOP and insulin resistance, representing a principal pathogenic factor in NAFLD, remains inconclusive. Here, SELENOP is linked to metabolic dysfunction-associated steatotic liver disease.